Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
45
FDA:45
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)No trials found
News
FDA Approves Phase 2 Trial Modification for Abion's Novel Lung Cancer Combination Therapy
The FDA has approved modifications to the Phase 2 clinical trial for vabametkib, Abion's c-MET targeted anticancer drug, in combination with lazertinib for non-small cell lung cancer patients. The trial will evaluate this novel combination therapy in patients who have developed resistance to EGFR-targeted treatments, addressing a significant unmet need in NSCLC treatment.